Verona, NJ, United States of America

Thomas A Daggs

USPTO Granted Patents = 3 

 


Average Co-Inventor Count = 5.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Thomas A Daggs: Innovator in Oral Delivery Systems

Introduction

Thomas A Daggs is a notable inventor based in Verona, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of oral delivery systems. With a total of 3 patents to his name, Daggs has focused on creating stable and effective methods for delivering calcitonin, a hormone used in the treatment of various medical conditions.

Latest Patents

Daggs' latest patents include innovative formulations for room temperature stable oral calcitonin. These patents disclose dosage forms for oral delivery of calcitonin that maintain stability at room temperature. Additionally, they describe methods for producing these stable dosage forms with low water content. The patents also encompass methods of treatment that involve administering these formulations, highlighting their potential for improving patient compliance and therapeutic outcomes.

Career Highlights

Throughout his career, Daggs has worked with prominent companies in the pharmaceutical industry. He has been associated with Enteris Biopharma, Inc. and Taurus Development Company LLC, where he has contributed his expertise in drug formulation and delivery systems. His work has been instrumental in advancing the field of oral drug delivery, particularly for challenging compounds like calcitonin.

Collaborations

Daggs has collaborated with several professionals in the industry, including Paul P Shields and James P Gilligan. These collaborations have allowed him to leverage diverse expertise and drive innovation in his projects.

Conclusion

Thomas A Daggs is a distinguished inventor whose work in oral delivery systems has the potential to transform patient treatment options. His innovative patents and collaborations reflect his commitment to advancing pharmaceutical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…